CHS	Cannabinoid Hyperemesis Syndrome
THC	Δ9-tetrahydrocannabinol THC
ECS	The Endocannabinoid System
CNS	Central nervous system
eCBs	Endocannabinoids
CBD	Cannabidiol
THCV	D9-tetrahydrocannabivarin
ROS	Reactive Oxygen Species
CBRs	Cannabinoid Receptors
DRO	Dronabinol
CBG	Cannbigerol
CBC	Cannabichromene
CBDV	Cannabidivarin
GPCR	G Protein-Coupled Receptor
CBDA	Cannabidiolic Acid
CBN	Cannabinol
CBL	Cannabicyclol
CBE	Cannabielsoin
CBF	Cannabifuran
TRP	Transient Receptor Potential
PPAR	Peroxisome Proliferator-Activated Receptors
TRPV1	Transient Receptor Potential Vanilloid Type 1
DSI	Depolarization-Induced Suppression of Inhibition
DSE	Depolarization-Induced Suppression of Excitation
5-HT	5-hydroxytryptamine
CYP450	Cytochrome P450
D11-OH-THC	D11-hydroxy-THC
D11-COOH-THC	D11-carboxy-THC
CBND	Cannabinodiol
EEG	Electroencephalography
ERP	Event Related Potentials
AD	Alzheimer’s Disease
Ab	Amyloid Beta
PSEN1	Presenilin-1
PSEN2	Presenilin-2
BDNF	Brain-Derived Neurotrophic Factor
LOAD	Late-Onset Alzheimer’s Disease
PD	Parkinson’s disease
LIDs	Levodopa-Induced Dyskinesias
GPl	Globus Pallidus
HD	Huntington’s Disease
MS	Multiple Sclerosis
CREA	Chronic Relapsing Experimental Allergic Encephalomyelitis
AEA	Anandamide
FAAH	Fatty Acid Amide Hydrolase
MCAO	Middle Cerebral Artery Occlusion
NMDA	N-methyl-D-aspartate
PEA	Palmitoylethanolamide
OEA	Oleoylethanolamide
AraS	N-arachidonoyl-L-serine
MAPK	Mitogen-Activated Protein Kinase
CRC	Colorectal Cancer
MAGL	Monoacylglycerol Lipase
LC3	Light Chain 3
NFAT	Nuclear Factor of Activated T Cells
LNCaP	Lymph Node Carcinoma of the Prostate
GB	Glioblastoma
TMZ	Temozolomide
CSCs	Cancer Stem Cells
PWH	People Living with HIV
ART	Antiretroviral Therapy
DDIs	Drug–Drug Interactions
SSRIs	Selective Serotonin Reuptake Inhibitors
OTC	Over the Counter
IBD	Inflammatory Bowel Disease
UC	Ulcerative Colitis
CD	Crohn’s Disease
BMT	Bone Marrow Transplant
EAE	Experimental Autoimmune Encephalomyelitis
MM	Medical Marijuana